| 引用本文: |
申岩.益气活血温心汤联合西药对慢性心力衰竭患者心功能、血浆脑钠肽及超敏C反应蛋白的影响[J].湖南中医药大学学报,2019,39(3):413-416[点击复制] |
|
| |
|
|
| 本文已被：浏览 1752次 下载 460次 |
| 益气活血温心汤联合西药对慢性心力衰竭患者心功能、血浆脑钠肽及超敏C反应蛋白的影响 |
| 申岩 |
| (唐山市工人医院分院, 河北 唐山 063000) |
| 摘要: |
| 目的 探讨益气活血温心汤联合西药对慢性心力衰竭（chronic heart failure，CHF）患者心功能、血浆脑钠肽（brain natriuretic peptide，BNP）、超敏C-反应蛋白（hypersensitive c-reactive protein，hs-CRP）等的影响。方法 将2017年10月至2018年10月本院门诊部收治的92例CHF患者随机分为观察组和对照组，每组46例。对照组采用西药常规治疗，观察组在对照组的基础上采用益气活血温心汤治疗。观察治疗后两组CHF患者的临床疗效，对比治疗前后两组CHF患者心功能[左心室射血分数（left ventricular ejection fractions，LVEF）及左心室舒张末期内径（left ventricular end diastolic diameter，LVEDD）]、血浆BNP浓度、hs-CRP水平及6 min步行距离。结果 （1）治疗后观察组患者的总有效率高于对照组，差异有统计学意义（P<0.05）；（2）治疗后，两组患者的6 min步行距离较治疗前升高，血浆BNP浓度、hs-CRP水平较治疗前比较有所下降，差异均有统计学意义（P<0.05），且观察组的6 min步行距离高于对照组（P<0.05），血浆BNP浓度、hs-CRP水平低于对照组（P<0.05）；（3）治疗后，两组患者的LVEF较治疗前升高，LVEDD较治疗前下降，差异均有统计学意义（P<0.05），且观察组的LVEF高于对照组，LVEDD低于对照组（P<0.05）。结论 益气活血温心汤联合西药治疗CHF患者疗效明显，可通过提高6 min步行距离、LVEF并且降低血浆BNP浓度、hs-CRP水平、LVEDD来实现，且优于单纯西药治疗。 |
| 关键词: 慢性心力衰竭 益气活血温心汤 血浆脑钠肽 超敏C-反应蛋白 6 min步行距离 左心室射血分数 左心室舒张末期内径 |
| DOI：10.3969/j.issn.1674-070X.2019.03.028 |
| 投稿时间：2018-10-29 |
| 基金项目:河北省中医药管理局项目（2014272） |
|
| Effects of Yiqi Huoxue Wenxin Decoction Combined with Western Medicine on Cardiac Function, Plasma Brain Natriuretic Peptide, and Hypersensitive C-Reactive Protein in Patients with Chronic Heart Failure |
| SHEN Yan |
| (Branch of Tangshan Workers' Hospital, Tangshan, Hebei 063000, China) |
| Abstract: |
| Objective To explore the effects of Yiqi Huoxue Wenxin Decoction combined with Western medicine on cardiac function, plasma brain natriuretic peptide (BNP), and hypersensitive C-reactive protein (hs-CRP) in patients with chronic heart failure (CHF). Methods A total of 92 CHF patients admitted to our hospital from October 2017 to October 2018 were randomly and equally divided into observation group and control group. The control group was treated with conventional Western medicine, while the observation group was treated with Yiqi Huoxue Wenxin Decoction in addition to conventional Western medicine. The clinical outcomes were compared between the two groups after treatment. The cardiac function[left ventricular ejection fraction (LVEF) and left ventricular end-diastolic diameter (LVEDD)], plasma BNP concentration, hs-CRP level, and 6-minute walking distance were compared between the two groups before and after treatment. Results (1) After treatment, the observation group had a significantly higher overall response rate than the control group (P<0.05); (2) After treatment, both groups had a significantly longer 6-minute walking distance and significantly reduced plasma BNP concentrations and hs-CRP levels (P<0.05). Moreover, the observation group had a significantly longer 6-minute walking distance and significantly lower plasma BNP concentration and hs-CRP level than the control group (P<0.05); (3) After treatment, both groups had significantly increased LVEF and significantly reduced LVEDD (P<0.05). Moreover, the observation group had a significantly higher LVEF and a significantly lower LVEDD than the control group (P<0.05). Conclusion Yiqi Huoxue Wenxin Decoction combined with Western medicine is substantially effective in the treatment of CHF patients by increasing 6-minute walking distance and LVEF as well as reducing plasma BNP concentration, hs-CRP level, and LVEDD. The combination therapy is superior to Western medicine alone. |
| Key words: chronic heart failure Yiqi Huoxue Wenxin Decoction plasma brain natriuretic peptide hypersensitive C-reactive protein 6-minute walking distance left ventricular ejection fraction left ventricular end-diastolic diameter |
|
二维码（扫一下试试看！） |
|
